JAK2 V617F VAF as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk
Alison Moliterno, MD, Johns Hopkins Medicine, Baltimore, MD, discusses the association between JAK2 V617F variant allele fraction (VAF), clinical phenotype, and venous thrombosis risk in patients with polycythemia vera (PV), discussing its role as a prognostic and diagnostic marker in this disease. This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Смотрите видео JAK2 V617F VAF as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk онлайн без регистрации, длительностью часов минут секунд в хорошем качестве. Это видео добавил пользователь VJHemOnc – Video Journal of Hematology & HemOnc 15 Ноябрь 2022, не забудьте поделиться им ссылкой с друзьями и знакомыми, на нашем сайте его посмотрели 9,887 раз и оно понравилось 75 людям.